About Bonraybio Co.
Bonraybio Co. is a pioneering biotechnology firm dedicated to advancing male reproductive health through innovative, AI-powered diagnostic solutions. The company specializes in comprehensive male infertility solutions, offering a range of in vitro diagnostic devices designed for precision and ease of use in clinical settings. Their flagship “LensHooke®” product line integrates advanced optical microscopy with sophisticated AI algorithms to provide fully automated and standardized analysis of critical semen parameters, including sperm concentration, motility, morphology, and pH. This technology significantly streamlines the diagnostic process for physicians, enabling rapid and accurate assessment of male fertility factors.
For healthcare professionals, Bonraybio’s offerings extend beyond basic semen analysis to include advanced sperm DNA fragmentation testing kits and optimum sperm selection devices. These tools are crucial for a more in-depth understanding of male fertility potential and for enhancing the success rates of assisted reproductive technologies (ART). The company’s commitment to medical innovation is further demonstrated by its continuous research and development efforts, which aim to expand into related fields such as embryo freezing and thawing technologies, as well as broader reproductive medicine, obstetrics, gynecology, and urology clinical testing. Bonraybio’s global presence, with products marketed in over 53 countries, underscores its role in addressing the growing challenge of infertility worldwide.
What Physicians Need to Know
For physicians, Bonraybio's solutions offer several key advantages. The AI-powered automation significantly reduces the subjectivity and potential for human error associated with manual semen analysis, leading to more objective and reproducible results. This allows for more confident clinical decision-making in identifying and treating infertility problems. The comprehensive data provided, including basic semen parameters and advanced sperm DNA fragmentation, offers a holistic view of male fertility. Furthermore, the user-friendly and compact design of their LensHooke analyzers makes them suitable for various clinical settings, including non-specialized laboratories, thereby enhancing accessibility to advanced diagnostics. The U.S. FDA approval for key products like the LensHooke X12PRO for sperm DNA fragmentation testing also provides a strong assurance of regulatory compliance and reliability.
The provided information does not explicitly detail integrations with Electronic Health Records (EHR) or other hospital information systems. The focus is on the standalone diagnostic capabilities and internal software/hardware integration of their devices.
Reviews & Opinions
Videos
News, demos, and interviews about Bonraybio Co..
Videos load interactively. If none appear, search YouTube for Bonraybio Co. →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]